TELA Bio, Inc.
TELA
$1.95
$0.010.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.94% | -6.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.94% | -6.90% | |||
| Cost of Revenue | -6.63% | 5.48% | |||
| Gross Profit | 11.41% | -12.64% | |||
| SG&A Expenses | 16.52% | -12.94% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.49% | -8.19% | |||
| Operating Income | -25.35% | 10.80% | |||
| Income Before Tax | -19.89% | 9.83% | |||
| Income Tax Expenses | 136.11% | -- | |||
| Earnings from Continuing Operations | -22.33% | 11.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.33% | 11.22% | |||
| EBIT | -25.35% | 10.80% | |||
| EBITDA | -26.17% | 11.14% | |||
| EPS Basic | -8.27% | 45.27% | |||
| Normalized Basic EPS | -6.10% | 44.40% | |||
| EPS Diluted | -8.27% | 45.27% | |||
| Normalized Diluted EPS | -6.10% | 44.40% | |||
| Average Basic Shares Outstanding | 12.96% | 62.22% | |||
| Average Diluted Shares Outstanding | 12.96% | 62.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||